W STRATEGIES, LLC for GLAXOSMITHKLINE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Educated staff on the negative consequences of legislative efforts to delay the transition of chlorofluorocarbon (CFC) based inhalers.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Small Business SMB
Educated committee staff on the important role the biopharmaceutical industry plays in job creation for small businesses in the United States.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Medicare/Medicaid MMM
Education on the importance of maintaining the competitive elements of the Part D prescription drug program and to oppose efforts to impose mandatory government rebates in that program. P.L. 112-25 - The Budget Control Act of 2011 as it relates to proposals to impose mandatory rebates in the Part D program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.